C. Liu

Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and very high PD-L1 expression.

S. Digumarthy, J. Heymach, M. Hellmann, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer.

B. Rose, M. Chatfield, C. S. Lee, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A natural food sweetener with anti-pancreatic cancer properties

C. Liu, L-H Dai, Dequan Dou, 2016, Oncogenesis.

Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV.

Xiang-ji Luo, Bai-he Zhang, C. Liu, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Metabolomics analysis of cervical cancer, cervical intraepithelial neoplasia and chronic cervicitis by 1H NMR spectroscopy.

N. Ye, P. Shi, C. Liu, 2015, European journal of gynaecological oncology.

Relating ovarian size to age, menopausal status, and use of hormones.

R. Kryscio, H. Gallion, J. van Nagell, 2001, Gynecologic oncology.

Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive?

N. Cheung, G. Heller, B. Kushner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

175P A study of neoadjuvant sintilimab combined with triplet chemotherapy of lipo-paclitaxel, cisplatin, and S-1 for resectable esophageal squamous cell carcinoma (ESCC)

N. Sun, Jianqing Xu, L. Xue, 2020 .

SOX10 is over-expressed in bladder cancer and contributes to the malignant bladder cancer cell behaviors

C. Qin, H. Yin, C. Liu, 2017, Clinical and Translational Oncology.

A natural food sweetener with anti-pancreatic cancer properties

C. Liu, L-H Dai, Dequan Dou, 2017, Oncogenesis.

Correction: MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

C. Croce, G. Romano, C. Taccioli, 2021, Oncogene.

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression.

S. Digumarthy, M. Hellmann, K. Kehl, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cancer: A new scoring system.

Z. Wang, G. Luo, H. Cheng, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

392P Clinical data from the real world: Efficacy analysis of ceritinib (450mg) in ALK-positive non-small cell lung cancer patients with brain metastases in China

Z. Qiu, Kai Wang, Meijuan Huang, 2020 .